Carter Caldwell

As the Penn Medicine Co-Investment Fund’s Program Director, Carter drives the fund’s investments in the cell therapy, gene therapy, and connected health sectors. Utilizing multiple decades of experience as both an entrepreneur and an investor, he sources investment opportunities, manages relationships with co-investors, completes due diligence, and supports the governance of the funded companies. Carter has spent much of his career in private equity and has been particularly focused on spearheading new investment efforts within the Healthcare IT, SaaS and Enterprise Software, AI, and Fintech industries, among others. He was previously a Managing Director with Cross Atlantic Capital Partners, a venture capital firm with 4 funds and over $500 million under management. He has a strong technology background, having founded and managed two software companies. Carter founded and served as COO of Quazant Technology, the developer of the Transaction Accelerator®, a high-speed transaction-processing database used in the Financial Services, Telecommunications and Enterprise Resource Planning industries. Prior to Quazant, Carter served as Director of Corporate Development and Product Manager at Acorn Systems, an activity-based cost analysis software and services company which was acquired by Ignite Technologies in July 2014. Frequently published in industry journals, Carter is a guest lecturer at Villanova Law School, and is a regular guest speaker at many industry events. He has served as a Judge for the nationally-recognized Ernst & Young Entrepreneur of the Year Competition, Wharton Business Plan Competition, Wharton Sustainable VC Investment Competition, and the New York and New England Venture Summits. Carter holds an MBA from Columbia University and a BA in Philosophy, Politics and Economics from the University of Pennsylvania.